• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

chronic kidney disease

Green traffic light
Pharma

FDA approves Corstasis' nasal spray as treatment for edema

The FDA has approved Corstasis Therapeutics’ nasal spray Enbumyst to relieve the edema associated with heart failure and kidney and liver disease.
Kevin Dunleavy Sep 15, 2025 3:33pm
newspaper

Ivonescimab, Fosun-Sitala, Hutchmed—Fierce Pharma Asia

Aug 29, 2025 8:15am
Graphic of a drop of blood made up of small data points and nodes

CSL's Venofer finally faces generic competition

Aug 13, 2025 2:06pm
Kerendia

FDA broadens label for Bayer's Kerendia to treat heart failure

Jul 14, 2025 8:39am
Image of a neon sign with the word no lit up next to an unlit yes

Manufacturing issues stunt Unicycive's kidney disease prospect

Jun 30, 2025 11:15am
Doctor diagnoses kidney

Second Novartis drug in IgAN troika crosses FDA finish line

Apr 3, 2025 10:56am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings